血栓疾病（急性心肌梗死、肺栓塞）的发病机制及诊疗，包括心肺疾病患者的运动康复治疗。

The pathogenesis, diagnosis and treatment of thrombotic diseases (acute myocardial infarction, pulmonary embolism), including exercise rehabilitation therapy for patients with cardiopulmonary diseases.

中国医师协会康复医师分会心肺康复专业委员会第二届委员会委员；上海市康复医学会心脏康复专业委员会青年委员；中国联盟心血管疾病预防与康复学会青年委员；中国联盟心血管疾病预防与康复学会上海市分联盟委员兼秘书长。 中国医师协会康复医师分会心肺康复专业委员会第二届委员会委员；上海市康复医学会心脏康复专业委员会青年委员；中国联盟心血管疾病预防与康复学会青年委员；中国联盟心血管疾病预防与康复学会上海市分联盟委员兼秘书长。

Second committee member of Chinese Medical Doctor Association (CMDA), Branch of Rehabilitation Physicians, Cardiopulmonary Rehabilitation Specialized Committee; Youth committee of Shanghai Rehabilitation Medicine Association, Cardiac Rehabilitation Specialized Committee; Youth committee of China Association on Cardiovascular Disease Prevention and Rehabilitation;Committee member and secretary general of China Association on Cardiovascular Disease Prevention and Rehabilitation, Shanghai sub Association.

分别主持1项国家自然基金青年项目及1项上海市卫生局课题；作为主要参与人参与2项国家自然基金面上项目。累计发表论文30余篇，以第一作者发表论文13篇，其中SCI 8篇。参与编写论著4本。 获得“同济大学附属同济医院优秀学科后备人才计划”。论文“定量评估肺栓塞患者的心肺储备功能”获得“第五届东方心脏病学会议”优秀论文；论文“The Inhibitory Effect of Vascular Smooth Muscle Cell Hyperplasia in Artificial Atherosclerotic Mouse Model via miR-155 Induced NoxA1 Down Regulation ”被2018年美国AHA/ATVB大会录用为壁报交流。

Presided as principal investigator over one National Natural Science Foundation Youth Project and one Shanghai Municipal Health Bureau Project, respectively. Participated as major researcher on two National Natural Science Foundation Projects. Published more than 30 papers, among which 13 papers as first author and eight of them are SCI indexed. Participated in writing and composing four books. Awarded the prize of "Excellent Discipline Reserved Talents Program of Tongji Hospital Affiliated to Tongji University". Thesis "Quantitative evaluation of cardiopulmonary reserve function in patients with pulmonary embolism" was awarded the "Excellent Thesis of the Fifth Session of Oriental Cardiology Conference". Abstract "The Inhibitory Effect of Vascular Smooth Muscle Cell Hyperplasia in Artificial Atherosclerotic Mouse Model via miR-155 Induced NoxA1 Down Regulation" was accepted as poster presentation in 2018 AHA/ATVB Conference in US.